Top

Published in:

01-02-2016 | Review

Therapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future Challenges

Authors: Hafsah Akhtar, Faiza Bukhari, Misbah Nazir, Muhammad Nabeel Anwar, Adeeb Shahzad

Published in: Neuroscience Bulletin | Issue 1/2016

Abstract

Depression is the most prevalent debilitating mental illness; it is characterized as a disorder of mood, cognitive function, and neurovegetative function. About one in ten individuals experience depression at some stage of their lives. Antidepressant drugs are used to reduce the symptoms but relapse occurs in ~20% of patients. However, alternate therapies like brain stimulation techniques have shown promising results in this regard. This review covers the brain stimulation techniques electroconvulsive therapy, transcranial direct current stimulation, repetitive transcranial magnetic stimulation, vagus nerve stimulation, and deep brain stimulation, which are used as alternatives to antidepressant drugs, and elucidates their research and clinical outcomes.

Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 2002, 167: 1253–1260.PubMedCentralPubMed

Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002, 53: 545–574.PubMedCrossRef

Koenigs M, Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009, 201: 239–243.PubMedCentralPubMedCrossRef

Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2007, 357: 1939–1945.PubMedCrossRef

Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002, 34: 13–25.PubMedCrossRef

Bora E, Harrison BJ, Davey CG, Yucel M, Pantelis C. Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder. Psychol Med 2012, 42: 671–681.PubMedCrossRef

Du MY, Wu QZ, Yue Q, Li J, Liao Y, Kuang WH, et al. Voxelwise meta–analysis of gray matter reduction in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012, 36: 11–16.PubMedCrossRef

Peng J, Liu J, Nie B, Li Y, Shan B, Wang G, et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study. Eur J Radiol 2011, 80: 395–399.PubMedCrossRef

Ritchey M, Dolcos F, Eddington KM, Strauman TJ, Cabeza R. Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. J Psychiatr Res 2011, 45: 577–587.PubMedCentralPubMedCrossRef

10.

Lee HY, Tae WS, Yoon HK, Lee BT, Paik JW, Son KR, et al. Demonstration of decreased gray matter concentration in the midbrain encompassing the dorsal raphe nucleus and the limbic subcortical regions in major depressive disorder: an optimized voxel-based morphometry study. J Affect Disord 2011, 133: 128–136.PubMedCrossRef

11.

Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53: 649–659.PubMedCrossRef

12.

Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996, 19: 179–200.PubMedCrossRef

13.

Kuo M-F, Nitsche MA. Exploring prefrontal cortex functions in healthy humans by transcranial electrical stimulation. Neurosci Bull 2015, 31: 198–206.PubMedCrossRef

14.

Schlaepfer TE, Bewernick BH, Kayser S, Hurlemann R, Coenen VA. Deep brain stimulation of the human reward system for major depression—rationale, outcomes and outlook. Neuropsychopharmacology 2014, 39: 1303–1314.PubMedCentralPubMedCrossRef

15.

Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45: 651–660.PubMedCrossRef

16.

Moreines JL, McClintock SM, Kelley ME, Holtzheimer PE, Mayberg HS. Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression. Depress Anxiety 2014, 31: 690–698.PubMedCentralPubMedCrossRef

17.

Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res2011, 45: 569–576.PubMedCrossRef

18.

Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006, 63: 1337–1344.PubMedCentralPubMedCrossRef

19.

Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA 2007, 298: 330–332.PubMedCrossRef

20.

Swartz CM, Nelson AI. Rational electroconvulsive therapy electrode placement. Psychiatry (Edgmont) 2005, 2: 37.

21.

Luria A, Simernitskaya E. Interhemispheric relations and the functions of the minor hemisphere. Neuropsychologia 1977, 15: 175–178.PubMedCrossRef

22.

Bragina N, Dobrokhotova T. Functional asymmetry of the human brain. Meditsina, Moscow 1981.

23.

Swartz CM, Larson G. Generalization of the effects of unilateral and bilateral ECT. Am J Psychiatry 1986, 143: 1040–1041.PubMedCrossRef

24.

The UERG. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003, 361: 799–808.CrossRef

25.

Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003, 19: 139–147.PubMedCrossRef

26.

Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004, 20: 13-20.PubMedCrossRef

27.

Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, et al. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul 2012, 5: 175–195.PubMedCentralPubMedCrossRef

28.

Nitsche M, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000, 527: 633–639.PubMedCentralPubMedCrossRef

29.

Priori A. Brain polarization in humans: a reappraisal of an old tool for prolonged non-invasive modulation of brain excitability. Clin Neurophysiol 2003, 114: 589–595.PubMedCrossRef

30.

Wagner T, Fregni F, Fecteau S, Grodzinsky A, Zahn M, Pascual-Leone A. Transcranial direct current stimulation: a computer-based human model study. Neuroimage 2007, 35: 1113–1124.PubMedCrossRef

31.

Arul-Anandam AP, Loo C. Transcranial direct current stimulation: a new tool for the treatment of depression? J Affect Disord 2009, 117: 137–145.PubMedCrossRef

32.

Taylor WD, MacFall JR, Payne ME, McQuoid DR, Provenzale JM, Steffens DC, et al. Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry 2004, 161: 1293–1296.PubMedCrossRef

33.

Boggio PS, Rigonatti SP, Ribeiro RB, Myczkowski ML, Nitsche MA, Pascual-Leone A, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008, 11: 249–254.PubMedCentralPubMed

34.

Palm U, Schiller C, Fintescu Z, Obermeier M, Keeser D, Reisinger E, et al. Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study. Brain Stimul 2012, 5: 242–251.PubMedCrossRef

35.

Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC‐stimulation‐induced after‐effects of human motor cortex excitability. Brain 2002, 125: 2238–2247.PubMedCrossRef

36.

Nitsche M, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. The Journal of physiology 2003, 553: 293–301.PubMedCentralPubMedCrossRef

37.

Martin DM, Alonzo A, Mitchell PB, Sachdev P, Gálvez V, Loo CK. Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open-label pilot study. J Affect Disord 2011, 134: 459–463.PubMedCrossRef

38.

Dell’Osso B, Zanoni S, Ferrucci R, Vergari M, Castellano F, D’Urso N, et al. Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients. European Psychiatry 2012, 27: 513–517.PubMedCrossRef

39.

Loo CK, Sachdev P, Martin D, Pigot M, Alonzo A, Malhi GS, et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol 2010, 13: 61–69.PubMedCrossRef

40.

Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985, 325: 1106–1107.CrossRef

41.

Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000, 406: 147–150.PubMedCrossRef

42.

Chen R, Classen J, Gerloff C, Celnik P, Wassermann E, Hallett M, et al. Depression of motor cortex excitability by lowssermann E, Hallett Mn. Nature 2000, 406: 147rtex. t of depre 48: 1398–1403.

43.

Johnson KA, Baig M, Ramsey D, Lisanby SH, Avery D, McDonald WM, et al. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul 2013, 6: 108–117.PubMedCentralPubMedCrossRef

44.

Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry 2003, 160: 835–845.PubMedCrossRef

45.

Pascual-Leone A, Rubio B, Pallardó F, Catalá MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996, 348: 233–237.PubMedCrossRef

46.

George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li X-B, et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000, 48: 962–970.PubMedCrossRef

47.

Chae J-H, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE, et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res2003, 37: 443–455.PubMedCrossRef

48.

Avery DH, Holtzheimer PE, Fawaz W, Russo J, Neumaier J, Dunner DL, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 2006, 59: 187–194.PubMedCrossRef

49.

O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007, 62: 1208–1216.PubMedCrossRef

50.

Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 2010, 3: 187–199.PubMedCrossRef

51.

McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MP, Berlim MT. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: An open label trial. J Affect Disord 2015, 173: 216–220.PubMedCrossRef

52.

Rokyta R, Fricová J. Neurostimulation methods in the treatment of chronic pain. Physiol Res 2012, 61: 23–31.

53.

Fricova J, Klirova M, Masopust V, Novak T, Verebova K, Rokyta R. Repetitive transcranial magnetic stimulation in the treatment of chronic orofacial pain. Physiol Res 2013, 62: S125–134.PubMed

54.

Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58: 347–354.PubMedCrossRef

55.

O’Reardon JP, Cristancho P, Peshek AD. Vagus nerve stimulation (VNS) and treatment of depression: to the brainstem and beyond. Psychiatry (Edgmont) 2006, 3: 54.

56.

Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther 2006, 318: 890–898.PubMedCrossRef

57.

Roosevelt RW, Smith DC, Clough RW, Jensen RA, Browning RA. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res 2006, 1119: 124–132.PubMedCentralPubMedCrossRef

58.

Daban C, Martinez-Aran A, Cruz N, Vieta E. Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord 2008, 110: 1–15.PubMedCrossRef

59.

Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002, 12: 527–544.PubMedCrossRef

60.

Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002, 51: 280–287.PubMedCrossRef

61.

Berry SM, Broglio K, Bunker M, Jayewardene A, Olin B, Rush AJ. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices (Auckl) 2013, 6: 17.

62.

Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005, 58: 355–363.PubMedCrossRef

63.

Corcoran CD, Thomas P, Phillips J, O’Keane V. Vagus nerve stimulation in chronic treatment-resistant depression Preliminary findings of an open-label study. Br J Psychiatry 2006, 189: 282–283.PubMedCrossRef

64.

Critchley HD, Lewis PA, Orth M, Josephs O, Deichmann R, Trimble MR, et al. Vagus nerve stimulation for treatment-resistant depression: behavioural and neural effects on encoding negative material. Psychosom Med 2007, 69: 17.PubMedCentralPubMedCrossRef

65.

George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005, 58: 364–373.PubMedCrossRef

66.

Christmas D, Steele JD, Tolomeo S, Eljamel MS, Matthews K. Vagus nerve stimulation for chronic major depressive disorder: 12-month outcomes in highly treatment-refractory patients. J Affect Disord 2013, 150: 1221–1225.PubMedCrossRef

67.

Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, et al. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul 2013, 6: 631–640.PubMedCrossRef

68.

Hariz MI, Blomstedt P, Zrinzo L. Deep brain stimulation between 1947 and 1987: the untold story. Neurosurg Focus 2010, 29: E1.PubMedCrossRef

69.

Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet 2005, 366: 1420–1422.PubMedCrossRef

70.

Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011, 168: 502–510.PubMedCrossRef

71.

Kosel M, Sturm V, Frick C, Lenartz D, Zeidler G, Brodesser D, et al. Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res2007, 41: 801–803.PubMedCrossRef

72.

Lozano AM, Lipsman N. Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron 2013, 77: 406–424.PubMedCrossRef

73.

Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33: 368–377.PubMedCrossRef

74.

Kombian SB, Malenka RC. Simultaneous LTP of non-NMDA-and LTD of NMDA-receptor-mediated responses in the nucleus accumbens. Nature 1994, 368: 242–246.PubMedCrossRef

75.

Nie Z, Yuan X, Madamba SG, Siggins GR. Ethanol decreases glutamatergic synaptic transmission in rat nucleus accumbens in vitro: naloxone reversal. J Pharmacol Exp Ther1993, 266: 1705–1712.PubMed

76.

Velasco F, Velasco M, Jiménez F, Velasco AL, Salin-Pascual R. Neurobiological background for performing surgical intervention in the inferior thalamic peduncle for treatment of major depression disorders. Neurosurgery 2005, 57: 439–448.PubMedCrossRef

77.

Sartorius A, Henn FA. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med Hypotheses 2007, 69: 1305–1308.PubMedCrossRef

78.

Hauptman JS, DeSalles AA, Espinoza R, Sedrak M, Ishida W. Potential surgical targets for deep brain stimulation in treatment-resistant depression. Neurosurg Focus 2008, 25: E3.PubMedCrossRef

79.

Jiménez F, Velasco F, Salin-Pascual R, Hernández JA, Velasco M, Criales JL, et al. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 2005, 57: 585–593.PubMedCrossRef

80.

Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT, et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression: clinical article. J Neurosurg 2012, 116: 315–322.PubMedCrossRef

81.

Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010, 67: 110–116.PubMedCrossRef

82.

Malone DA, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009, 65: 267–275.PubMedCentralPubMedCrossRef

83.

Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012, 64: 238-258.PubMedCentralPubMedCrossRef

84.

Reid IC, Stewart CA. How antidepressants work New perspectives on the pathophysiology of depressive disorder. Br J Psychiatry 2001, 178: 299–303.PubMedCrossRef

85.

Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Bermpohl F, et al. Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder. Biol Psychiatry 2008, 63: 369–376.PubMedCrossRef

86.

Altshuler L, Bookheimer S, Townsend J, Proenza MA, Sabb F, Mintz J, et al. Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study. Bipolar Disord 2008, 10: 708–717.PubMedCentralPubMedCrossRef

87.

Wahlund B, von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology 2003, 28: S21–26.PubMedCrossRef

88.

Speer AM, Kimbrell TA, Wassermann EM, Repella JD, Willis MW, Herscovitch P, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000, 48: 1133–1141.PubMedCrossRef

89.

Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingström A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000, 47: 1043–1049.PubMedCrossRef

90.

Scott BW, Wojtowicz JM, Burnham WM. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Experimental neurology 2000, 165: 231–236.PubMedCrossRef

91.

Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull 2007, 72: 208–214.PubMedCrossRef

92.

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Meglio M, et al. Effects of vagus nerve stimulation on cortical excitability in epileptic patients. Neurology 2004, 62: 2310–2312.PubMedCrossRef

93.

Zuo Y, Smith DC, Jensen RA. Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats. Physiol Behav 2007, 90: 583–589.PubMedCentralPubMedCrossRef

94.

Bajbouj M, Lang UE, Niehaus L, Hellen FE, Heuser I, Neu P. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. J Psychiatric Res 2006, 40: 322–327.CrossRef

95.

Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng 2007, 9: 527–565.PubMedCrossRef

96.

Eranti S, Psych M, Mogg A, Pluck G, Landau S, Purvis R, et al. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007, 164: 73–81.PubMedCrossRef

97.

White PF, Amos Q, Zhang Y, Stool L, Husain MM, Thornton L, et al. Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anaesth Analg 2006, 103: 76–80.CrossRef

98.

Dunner DL, Rush AJ, Russell JM, Burke M, Woodard S, Wingard P, et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry 2006, 67:688–695.PubMedCrossRef

99.

Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 2005, 29: 493–500.PubMedCrossRef

100.

Sackeim HA, Prudic J, Devanand D, Nobler MS, Lisanby SH, Peyser S, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000, 57: 425–434.PubMedCrossRef

101.

Walter G, Martin J, Kirkby K, Pridmore S. Transcranial magnetic stimulation: experience, knowledge and attitudes of recipients. Aust N Z J Psychiatry 2001, 35: 58–61.PubMedCrossRef

102.

Grunhaus L, Dannon PN, Schreiber S, Dolberg OH, Amiaz R, Ziv R, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000, 47: 314–324.PubMedCrossRef

103.

Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000, 3: 129–134.PubMedCrossRef

104.

Garcia-Toro M, Mayol A, Arnillas H, Capllonch I, Ibarra O, Crespí M, et al. Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Disord 2001, 64: 271–275.PubMedCrossRef

105.

Aleman A, Slotema C, Sommer I. rTMS deserves a fair chance as a novel treatment for depression. Acta Psychiatr Scand 2014, 130: 324–325.PubMedCrossRef

106.

Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, et al. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiatry 2014, 76: 176–185.PubMedCrossRef

107.

Neuhaus A, Luborzewski A, Rentzsch J, Brakemeier E, Opgen-Rhein C, Gallinat J, et al. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. J Affect Disord 2007, 100: 123–128.PubMedCrossRef

Title: Therapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future Challenges
Authors: Hafsah Akhtar
Faiza Bukhari
Misbah Nazir
Muhammad Nabeel Anwar
Adeeb Shahzad
Publication date: 01-02-2016
Publisher: Springer Singapore
Published in: Neuroscience Bulletin / Issue 1/2016
Print ISSN: 1673-7067
Electronic ISSN: 1995-8218
DOI: https://doi.org/10.1007/s12264-015-0009-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Therapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future Challenges

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

TNP-ATP is Beneficial for Treatment of Neonatal Hypoxia-Induced Hypomyelination and Cognitive Decline

The Orphan Nuclear Receptor TLX/NR2E1 in Neural Stem Cells and Diseases

Upregulation of Chemokine CXCL12 in the Dorsal Root Ganglia and Spinal Cord Contributes to the Development and Maintenance of Neuropathic Pain Following Spared Nerve Injury in Rats

Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress

Gabapentinoid Insensitivity after Repeated Administration is Associated with Down-Regulation of the α2δ-1 Subunit in Rats with Central Post-Stroke Pain Hypersensitivity

Association of Optic Radiation Integrity with Cortical Thickness in Children with Anisometropic Amblyopia